1,574 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B Buy
Article Searches
Bristol-Myers' Opdivo Receives Positive CHMP Opinion for RCC http://www.zacks.com/stock/news/338106/bristol-myers-opdivo-receives-positive-chmp-opinion-for-rcc?cid=CS-ZC-FT-338106 Nov 16, 2018 - Bristol-Myers' (BMY) immuno-oncology drug Opdivo combined with low-dose Yervoy gets positive opinion from CHMP for the treatment of intermediate- and poor-risk advanced RCC.
Mallinckrodt Gets FDA Committee Vote for Abuse-Deterrent Drug http://www.zacks.com/stock/news/337863/mallinckrodt-gets-fda-committee-vote-for-abuse-deterrent-drug?cid=CS-ZC-FT-337863 Nov 15, 2018 - The FDA's Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee vote for Mallinckrodt (MNK) abuse-deterrent drug.
Tesaro, Clovis Rally on FDA Priority Review for Lynparza sNDA http://www.zacks.com/stock/news/337557/tesaro-clovis-rally-on-fda-priority-review-for-lynparza-snda?cid=CS-ZC-FT-337557 Nov 14, 2018 - PARP inhibitor makers get a boost following priority review for AstraZeneca???s (AZN) label expansion application for Lynparza as a first-line maintenance treatment for ovarian cancer.
Merck Starts Rolling BLA Submission for Ebola Vaccine V920 http://www.zacks.com/stock/news/337545/merck-starts-rolling-bla-submission-for-ebola-vaccine-v920?cid=CS-ZC-FT-337545 Nov 14, 2018 - Merck (MRK) begins the rolling submission of a BLA for its investigational Ebola vaccine candidate V920 to the FDA.
Richard Bernstein Advisors LLC Buys SPDR Select Sector Fund - Health Care, PowerShares DB ... http://www.gurufocus.com/news/770018/richard-bernstein-advisors-llc-buys-spdr-select-sector-fund--health-care-powershares-db-optimum-yield-diversified-commoditi-unitedhealth-group-inc-sells-ishares-core-msci-emerging-markets-vaneck-vectors-junior-gold-miners-general-electric-co Nov 13, 2018 - Richard Bernstein Advisors LLC Buys SPDR Select Sector Fund - Health Care, PowerShares DB Optimum Yield Diversified Commoditi, UnitedHealth Group Inc, Sells iShares Core MSCI Emerging Markets, VanEck Vectors Junior Gold Miners, General Electric Co, Stocks: UNH,PFE,ABBV,MRK,CCK,INTC,XLV,PDBC,AMGN,ABT,MDT,BM, release date:Nov 13, 2018
ClearBridge All Cap Value Strategy Portfolio Manager Commentary Q3 2018 https://seekingalpha.com/article/4221596-clearbridge-cap-value-strategy-portfolio-manager-commentary-q3-2018?source=feed_all_articles Nov 13, 2018 - ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas
Tracking Dan Loeb's Third Point Portfolio - Q3 2018 Update https://seekingalpha.com/article/4221202-tracking-dan-loebs-third-point-portfolio-q3-2018-update?source=feed_all_articles Nov 12, 2018 - Dan Loeb's 13F portfolio value decreased from $14.35B to $12.84B this quarter. The number of positions decreased from 38 to 31.Third Point added American Express and increased Campbell Soup while drop
Merck's (MRK) Keytruda Gets FDA Approval for Liver Cancer http://www.zacks.com/stock/news/336981/mercks-mrk-keytruda-gets-fda-approval-for-liver-cancer?cid=CS-ZC-FT-336981 Nov 12, 2018 - Merck's (MRK) Keytruda gains FDA approval for hepatocellular carcinoma (HCC) in patients previously treated with sorafenib.
Third Point, LLC Buys American Express Co, Campbell Soup Co, Merck Inc, Sells NXP ... http://www.gurufocus.com/news/768541/third-point-llc-buys-american-express-co-campbell-soup-co-merck-inc-sells-nxp-semiconductors-nv-facebook-inc-vulcan-materials-co Nov 09, 2018 - Third Point, LLC Buys American Express Co, Campbell Soup Co, Merck Inc, Sells NXP Semiconductors NV, Facebook Inc, Vulcan Materials Co, Stocks: CPB,MSFT,ADBE,DE,AXP,MRK,SHPG,IQV,FANG,WPX,NFLX,SP, release date:Nov 09, 2018
Endo (ENDP) Stock Declines Despite Q3 Earnings & Revenue Beat http://www.zacks.com/stock/news/336822/endo-endp-stock-declines-despite-q3-earnings-revenue-beat?cid=CS-ZC-FT-336822 Nov 09, 2018 - Endo (ENDP) tops revenues and earnings expectations in the third quarter and raises its annual view. However, the results from the cellulite treatment trial are disappointing.

Pages: 123456...158

Page 1>

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $85.13 $197.65B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Merck & Company